Screener
CNS Pharmaceuticals CNSP Q2 2026 earnings
Reported August 12, 2026 · Before market open
EPS-$0.38Miss by $0.14
EPS estimate-$0.24
Next report
Nov 18, 2026 (in 2 months)EPS estimate-$0.27
Versus estimates
Diluted EPS
FAQ
- When did CNS Pharmaceuticals report Q2 2026 earnings?
- CNS Pharmaceuticals (CNSP) reported Q2 2026 earnings on August 12, 2026 before market open.
- What were CNS Pharmaceuticals's Q2 2026 revenue and EPS?
- CNS Pharmaceuticals reported eps of $-0.38 for Q2 2026.
- Did CNS Pharmaceuticals beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.24 by $0.14.
- How did CNS Pharmaceuticals's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 94.1% from $-6.42.
- Where can I find CNS Pharmaceuticals's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001683168-26-006224) directly on SEC EDGAR. The filing index links above go to sec.gov.
